Journal of Pediatric Endocrinology and Metabolism · 2006 · 23 citations · 14 references
MedicineEndocrinologyPediatricsPediatric Clinical PharmacologyPediatric EndocrinologyPediatric TherapeuticsChild GrowthGenetics Of Growth DisordersGrowth DisordersPediatric Endocrine DisordersDisease Severity EstimationDisease Severity Index
OBJECTIVE: To evaluate the effect of disease severity and colchicine treatment on height and weight parameters in children with familial Mediterranean fever (FMF). METHODS: Thirty prepubertal children (19 M, 11 F) were studied retrospectively. Z-score values of height, growth velocity, weight and body mass index were obtained over 1.84 +/- 1.14 years before and 2.58 +/- 1.55 years during colchicine therapy. Disease severity was evaluated by a specific score for FMF. RESULTS: By comparison to growth before treatment, during colchicine therapy height SDS increased from -1.00 +/- 1.17 to -0.54 +/- 0.96 (p < 0.001) and weight SDS increased from -0.74 +/- 1.09 to -0.47 +/- 1.06 (p = 0.008). An effect of disease severity on growth pattern could not be detected. Height SDS during therapy was negatively correlated with age at colchicine initiation. CONCLUSIONS: Colchicine therapy has a positive effect on both height and weight parameters in children with FMF. Early initiation of treatment is beneficial for height gain.
14
Body mass index reference curves for the UK, 1990.
Tim Cole, Jenny Freeman, M A Preece · Archives of Disease in Childhood · 1995 · 2.1K citations · Full text
Fabrizio De Benedetti, Tonino Alonzi, Antonia Moretta et al. · Journal of Clinical Investigation · 1997 · 530 citations · Full text
Medicine, Endocrinology, Immunology +15